1 Hr
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
1 Hrالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
1 HrReady to play
Ready to play
A clinical trial involving 60 adults with chronic nasal obstruction found that a spray combining oxymetazoline and budesonide was more effective than budesonide alone: 83% of those using the combination improved after four weeks, compared with 36% in the other group. After two weeks, obstruction severity had decreased by 69% among users of the combination treatment, versus 41% in the budesonide-only group. No signs of rebound congestion were recorded among combination-treatment users during the first four weeks or in the week after they stopped using the decongestant. The researchers describe the treatment as promising, but the trial lasted only seven weeks and included just 60 participants, so larger, longer studies are needed to assess its effectiveness and long-term safety.
Notice: This Is an AI-Generated Summary
Comments (0)